Selon un communiqué de PositiveID Corporation, l’entreprise américaine qui commercialise la puce RFID sous-cutanée VeriChip, l’armée israélienne s’apprêterait à pucer ses soldats pour intervenir en situation d’urgence. La puce VeriChip, apprend-on, peut être couplée à une caméra capable de recevoir les informations communiquées par le dispositif à radiofréquences et les données de géolocalisation par GPS (transmises sans fil), ainsi qu’à une base de données Internet qui centralise et stocke les images et informations récupérées pendant les opérations d’urgence.
October 11, 2011
PositiveID Corporation Receives VeriChip Order for Use With Israeli Military
DELRAY BEACH, Fla., Oct. 11, 2011 (GLOBE NEWSWIRE) — PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that it has received an order for its VeriChip™ microchip to be used for disaster preparedness and emergency management in Israel by an integration partner.
The VeriChip radio frequency identification (RFID) microchip was cleared by the U.S. Food and Drug Administration in 2004 for patient identification. The VeriChip can also be used to assist in the management of emergency situations and disaster recovery in conjunction with a customized camera capable of receiving both RFID scanned data and GPS data wirelessly, and a Web-enabled database for gathering and storing information and images captured during emergency response operations.
The Company’s integration partner intends to provide the microchips to the Israel Defense Forces (IDF), the State of Israel’s military force.
Marc Poulshock, PositiveID’s Vice President of Business Development, said, "We believe there are many important applications for the VeriChip and our associated intellectual property including next-generation identification and bio-sensing capabilities. Our partner is looking to help healthcare organizations, militaries including the IDF, and governments with their disaster preparedness and emergency response needs."
About PositiveID Corporation
PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MicroFluidic Systems, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.